Showing results (151-160 of 160) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
Life Science Alliance|December 12, 2019
Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosisRobert Brenig, Oltin T Pop, Evangelos Triantafyllou, et al.
Gastroenterology|December 6, 2014
Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTKChristine Bernsmeier, Oltin T Pop, Arjuna Singanayagam, et al.
Journal for Immunotherapy of Cancer|December 22, 2021
Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapyJonas Bochem, Henning Zelba, Janine Spreuer, et al.
Journal of Hepatology|January 16, 2025
Circulating monocytes upregulate CD52 and sustain innate immune function in cirrhosis unless acute decompensation emergesAnne Geng, Robert G Brenig, Julien Roux, et al.
Gut|April 29, 2017
MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failureEvangelos Triantafyllou, Oltin T Pop, Lucia A Possamai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2022
Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell CarcinomaAndrey A Yurchenko, Oltin T Pop, Meriem Ighilahriz, et al.
American Journal of Respiratory and Critical Care Medicine|April 16, 2024
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint BlockadeNina Wyss, Fiamma Berner, Vincent Walter, et al.
American Journal of Respiratory and Critical Care Medicine|August 4, 2022
Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19Tobias Sinnberg, Christa Lichtensteiger, Omar Hasan Ali, et al.
Immunity|October 14, 2020
CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T CellsMatthias Braun, Amelia Roman Aguilera, Ashmitha Sundarrajan, et al.
Pageof 16